drugset / Trial / NCT01372839

Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome

NCT01372839 ↗

Phase 4 Unknown 300 enrolled Xijing Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Compare with regular regimen, the aim of this study is to testify whether having more statin during PCI will benefit in Chinese population, and to find out optimal dose of the drug for patient after PCI.

Timeline

Start
2010-07
Primary completion
2012-07
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule 40 mg —